Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation: 02/07/2019, Revision: 21, Status: Authorised
الصحة واللياقة البدنية
Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation: 02/07/2019, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation: 02/07/2019, Revision: 21, Status: Authorised
AAdmin
٢١ يوليو ٢٠٢٦
1 دقيقة قراءة
